Search results
Glenn Close ‘hit hard’ with Covid and RSV at same time, forced to delay filming ‘Knives Out 3’ | CNN
CNN.com· 9 hours agoRespiratory syncytial virus, known as RSV, is a common respiratory virus that typically causes...
New RSV shots tied to rare nervous system disorder — should you worry?
LiveScience· 6 days agoThe new RSV vaccines approved for older adults may be linked to a slightly increased risk of a rare...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 7 days agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Study marks increase in pediatric RSV hospitalizations seen postpandemic
Medical Xpress· 1 day agoHospital volumes for pediatric respiratory syncytial virus (RSV) rose significantly following the...
Moderna Just Gave Investors Another Reason to Buy the Stock
The Motley Fool via AOL· 4 days agoThanks to its deep pipeline, it is moving beyond its coronavirus portfolio. The recent approval of...
Gateway - Quartz
Quartz· 22 hours agoModerna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in results from a phase-3 clinical trial. The pharma Moderna ...
Children with RSV during 2022-23 needed more advanced support, study finds
Center for Infectious Disease Research and Policy· 5 days agoA study yesterday in JAMA Network Open shows a 70% increase in the number of children requiring...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
Having symptoms after getting a COVID vaccine may indicate robust immune response
Center for Infectious Disease Research and Policy· 2 days agoOne and 6 months after the second vaccine dose, fatigue, malaise, chills, and headache were each...